Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	transferase activity, transferring sulphur-containing groups	CDKAL1 ACSM3 SULT6B1 GAL3ST3 HS3ST2	6.54e-05	74	114	5	GO:0016782
GeneOntologyMolecularFunction	N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity	CHSY3 CHPF	1.92e-04	4	114	2	GO:0050510
GeneOntologyMolecularFunction	UDP-glycosyltransferase activity	LARGE2 XYLT2 CHSY3 WDFY3 CHPF MGAT5B	2.48e-04	153	114	6	GO:0008194
GeneOntologyMolecularFunction	glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity	CHSY3 CHPF	4.77e-04	6	114	2	GO:0047238
GeneOntologyBiologicalProcess	cell quiescence	NFIA NFIB NFIX	8.79e-06	8	113	3	GO:0044838
GeneOntologyBiologicalProcess	glial cell fate specification	NFIA NFIB NFIX	1.31e-05	9	113	3	GO:0021780
GeneOntologyBiologicalProcess	proteoglycan biosynthetic process	XYLT2 GAL3ST3 CHSY3 CHPF HS3ST2	4.11e-05	70	113	5	GO:0030166
GeneOntologyCellularComponent	non-motile cilium	IFT140 PEX6 PTGS1 FAM161A PAFAH1B1 PCDH15 IFT122	1.07e-04	196	115	7	GO:0097730
GeneOntologyCellularComponent	photoreceptor cell cilium	IFT140 PEX6 PTGS1 FAM161A PCDH15 IFT122	1.20e-04	139	115	6	GO:0097733
GeneOntologyCellularComponent	9+0 non-motile cilium	IFT140 PEX6 PTGS1 FAM161A PCDH15 IFT122	2.03e-04	153	115	6	GO:0097731
GeneOntologyCellularComponent	stereocilium	ESPNL PKHD1L1 PAFAH1B1 PCDH15	5.70e-04	69	115	4	GO:0032420
GeneOntologyCellularComponent	intraciliary transport particle A	IFT140 IFT122	8.22e-04	8	115	2	GO:0030991
GeneOntologyCellularComponent	stereocilium bundle	ESPNL PKHD1L1 PAFAH1B1 PCDH15	9.51e-04	79	115	4	GO:0032421
Domain	CTF_NFI	NFIA NFIB NFIC NFIX	1.23e-09	4	112	4	PF00859
Domain	CTF_NFI_1	NFIA NFIB NFIC NFIX	1.23e-09	4	112	4	PS00349
Domain	CTF_NFI_2	NFIA NFIB NFIC NFIX	1.23e-09	4	112	4	PS51080
Domain	CTF/NFI_DNA-bd-dom	NFIA NFIB NFIC NFIX	1.23e-09	4	112	4	IPR020604
Domain	NfI_DNAbd_pre-N	NFIA NFIB NFIC NFIX	1.23e-09	4	112	4	PF10524
Domain	CTF/NFI	NFIA NFIB NFIC NFIX	1.23e-09	4	112	4	IPR000647
Domain	CTF/NFI_DNA-bd_N	NFIA NFIB NFIC NFIX	1.23e-09	4	112	4	IPR019548
Domain	CTF/NFI_DNA-bd_CS	NFIA NFIB NFIC NFIX	1.23e-09	4	112	4	IPR019739
Domain	MAD_homology1_Dwarfin-type	NFIA NFIB NFIC NFIX	5.84e-07	12	112	4	IPR003619
Domain	DWA	NFIA NFIB NFIC NFIX	5.84e-07	12	112	4	SM00523
Domain	MH1	NFIA NFIB NFIC NFIX	5.84e-07	12	112	4	PF03165
Domain	AAA	TOR2A NAIP PEX6 RNF213 ABCA7 CHTF18 ABCD3	2.58e-05	144	112	7	SM00382
Domain	AAA+_ATPase	TOR2A NAIP PEX6 RNF213 ABCA7 CHTF18 ABCD3	2.58e-05	144	112	7	IPR003593
Domain	ssDNA-bd_transcriptional_reg	NFIC NFIX	1.07e-04	3	112	2	IPR009044
Domain	LNS2	PITPNM2 PITPNM3	5.26e-04	6	112	2	IPR013209
Domain	PI_transfer	PITPNM2 PITPNM3	5.26e-04	6	112	2	IPR001666
Domain	LNS2	PITPNM2 PITPNM3	5.26e-04	6	112	2	SM00775
Domain	DDHD	PITPNM2 PITPNM3	5.26e-04	6	112	2	PF02862
Domain	DDHD	PITPNM2 PITPNM3	5.26e-04	6	112	2	PS51043
Domain	DDHD_dom	PITPNM2 PITPNM3	5.26e-04	6	112	2	IPR004177
Domain	LNS2	PITPNM2 PITPNM3	5.26e-04	6	112	2	PF08235
Domain	LNS2/PITP	PITPNM2 PITPNM3	5.26e-04	6	112	2	IPR031315
Domain	DDHD	PITPNM2 PITPNM3	5.26e-04	6	112	2	SM01127
Domain	Chond_GalNAc	CHSY3 CHPF	9.75e-04	8	112	2	IPR008428
Domain	CHGN	CHSY3 CHPF	9.75e-04	8	112	2	PF05679
Domain	P-loop_NTPase	DNHD1 MYO9A TOR2A NAIP PEX6 RNF213 DDX56 ABCA7 CHTF18 SULT6B1 ABCD3 GAL3ST3 HS3ST2	1.70e-03	848	112	13	IPR027417
Domain	-	DNHD1 TOR2A NAIP PEX6 RNF213 DDX56 ABCA7 CHTF18 SULT6B1 ABCD3 GAL3ST3 HS3ST2	1.73e-03	746	112	12	3.40.50.300
Domain	DHR-1_domain	DOCK2 DOCK6	1.89e-03	11	112	2	IPR027007
Domain	DHR_2	DOCK2 DOCK6	1.89e-03	11	112	2	PS51651
Domain	DHR_1	DOCK2 DOCK6	1.89e-03	11	112	2	PS51650
Domain	DHR-2	DOCK2 DOCK6	1.89e-03	11	112	2	PF06920
Domain	DOCK	DOCK2 DOCK6	1.89e-03	11	112	2	IPR026791
Domain	DOCK_C	DOCK2 DOCK6	1.89e-03	11	112	2	IPR010703
Domain	DOCK-C2	DOCK2 DOCK6	1.89e-03	11	112	2	PF14429
Domain	DHR-2	DOCK2 DOCK6	1.89e-03	11	112	2	IPR027357
Domain	RasGAP	RASA2 RASAL2	3.09e-03	14	112	2	SM00323
Domain	RasGAP_CS	RASA2 RASAL2	3.09e-03	14	112	2	IPR023152
Domain	Bbox_C	MID2 TRIM66	3.56e-03	15	112	2	IPR003649
Domain	RasGAP	RASA2 RASAL2	3.56e-03	15	112	2	PF00616
Domain	BBC	MID2 TRIM66	3.56e-03	15	112	2	SM00502
Domain	RAS_GTPASE_ACTIV_1	RASA2 RASAL2	3.56e-03	15	112	2	PS00509
Domain	Peptidase_C2	CAPN10 ADGB	3.56e-03	15	112	2	PF00648
Domain	CysPc	CAPN10 ADGB	3.56e-03	15	112	2	SM00230
Domain	Peptidase_C2_calpain_cat	CAPN10 ADGB	3.56e-03	15	112	2	IPR001300
Domain	RAS_GTPASE_ACTIV_2	RASA2 RASAL2	3.56e-03	15	112	2	PS50018
Domain	CALPAIN_CAT	CAPN10 ADGB	3.56e-03	15	112	2	PS50203
Domain	-	IFT140 MET PAFAH1B1 IFT122 WDFY3 MAPKBP1 RMC1	3.95e-03	333	112	7	2.130.10.10
Domain	-	RASA2 RASAL2	4.05e-03	16	112	2	1.10.506.10
Domain	WD40/YVTN_repeat-like_dom	IFT140 MET PAFAH1B1 IFT122 WDFY3 MAPKBP1 RMC1	4.08e-03	335	112	7	IPR015943
Domain	ARM-type_fold	DOCK2 PDS5B APOB SDAD1 NUP188 WDFY3 SYMPK	4.35e-03	339	112	7	IPR016024
Domain	RasGAP_dom	RASA2 RASAL2	5.12e-03	18	112	2	IPR001936
Pathway	REACTOME_RNA_POLYMERASE_III_TRANSCRIPTION_TERMINATION	NFIA NFIB NFIC NFIX	9.08e-06	23	83	4	M1024
Pathway	WP_GLYCOSAMINOGLYCAN_SYNTHESIS_IN_FIBROBLASTS	XYLT2 CHSY3 CHPF HS3ST2	9.58e-05	41	83	4	M48095
Pathway	REACTOME_RNA_POLYMERASE_III_TRANSCRIPTION	NFIA NFIB NFIC NFIX	9.58e-05	41	83	4	M739
Pathway	REACTOME_REGULATION_OF_MITF_M_DEPENDENT_GENES_INVOLVED_IN_CELL_CYCLE_AND_PROLIFERATION	HINT1 MET TCF7L1	1.26e-04	17	83	3	M48240
Pathway	PID_HNF3A_PATHWAY	APOB NFIA NFIB NFIC	1.27e-04	44	83	4	M285
Pathway	REACTOME_CHONDROITIN_SULFATE_DERMATAN_SULFATE_METABOLISM	XYLT2 GPC4 CHSY3 CHPF	1.78e-04	48	83	4	MM14696
Pathway	REACTOME_CHONDROITIN_SULFATE_DERMATAN_SULFATE_METABOLISM	XYLT2 GPC4 CHSY3 CHPF	2.09e-04	50	83	4	M678
Pathway	KEGG_GLYCOSAMINOGLYCAN_BIOSYNTHESIS_CHONDROITIN_SULFATE	XYLT2 CHSY3 CHPF	2.80e-04	22	83	3	M19166
Pathway	REACTOME_MET_INTERACTS_WITH_TNS_PROTEINS	MET TNS3	3.39e-04	5	83	2	M27775
Pathway	REACTOME_SYNTHESIS_OF_PI	PITPNM2 PITPNM3	3.39e-04	5	83	2	M26962
Pathway	REACTOME_MET_INTERACTS_WITH_TNS_PROTEINS	MET TNS3	3.39e-04	5	83	2	MM15514
Pathway	REACTOME_SYNTHESIS_OF_PI	PITPNM2 PITPNM3	3.39e-04	5	83	2	MM14587
Pathway	REACTOME_SCAVENGING_BY_CLASS_B_RECEPTORS	APOB SCARB1	5.06e-04	6	83	2	M27220
Pathway	REACTOME_GLYCOSAMINOGLYCAN_METABOLISM	XYLT2 GPC4 CHSY3 CHPF HS3ST2	7.86e-04	123	83	5	MM14623
Pathway	REACTOME_GLYCOSAMINOGLYCAN_METABOLISM	XYLT2 GPC4 CHSY3 CHPF HS3ST2	8.76e-04	126	83	5	M695
Pathway	REACTOME_REGULATION_OF_MITF_M_DEPENDENT_GENES_INVOLVED_IN_CELL_CYCLE_AND_PROLIFERATION	HINT1 TCF7L1	9.37e-04	8	83	2	MM17229
Pathway	KEGG_MEDICUS_REFERENCE_CHONDROITIN_SULFATE_BIOSYNTHESIS	CHSY3 CHPF	9.37e-04	8	83	2	M47920
Pubmed	Expression patterns of the four nuclear factor I genes during mouse embryogenesis indicate a potential role in development.	NFIA NFIB NFIC NFIX	1.17e-10	4	116	4	9056636
Pubmed	Nuclear factor one transcription factors as epigenetic regulators in cancer.	NFIA NFIB NFIC NFIX	1.17e-10	4	116	4	28076901
Pubmed	Transcription factor NF 1 expression in involuting mammary gland.	NFIA NFIB NFIC NFIX	1.17e-10	4	116	4	10959417
Pubmed	Chromosomal localization of the four genes (NFIA, B, C, and X) for the human transcription factor nuclear factor I by FISH.	NFIA NFIB NFIC NFIX	1.17e-10	4	116	4	7590749
Pubmed	Altered expression of the developmentally regulated NFI gene family during phorbol ester-induced differentiation of human leukemic cells.	NFIA NFIB NFIC NFIX	1.17e-10	4	116	4	9052991
Pubmed	Genomic organization, splice products and mouse chromosomal localization of genes for transcription factor Nuclear Factor One.	NFIA NFIB NFIC NFIX	1.17e-10	4	116	4	12568726
Pubmed	Regulation of the CYP3A4 and CYP3A7 promoters by members of the nuclear factor I transcription factor family.	NFIA NFIB NFIC NFIX	5.86e-10	5	116	4	19706729
Pubmed	Temporal control of a dendritogenesis-linked gene via REST-dependent regulation of nuclear factor I occupancy.	NFIA NFIB NFIC NFIX	1.75e-09	6	116	4	21270437
Pubmed	NFI in the development of the olfactory neuroepithelium and the regulation of olfactory marker protein gene expression.	NFIA NFIB NFIC NFIX	4.08e-09	7	116	4	10762365
Pubmed	TGF-β/NF1/Smad4-mediated suppression of ANT2 contributes to oxidative stress in cellular senescence.	NFIA NFIB NFIC NFIX	4.08e-09	7	116	4	25220407
Pubmed	Single-Cell RNA-Seq Analysis of Retinal Development Identifies NFI Factors as Regulating Mitotic Exit and Late-Born Cell Specification.	NFIA NFIB NFIX	3.62e-08	3	116	3	31128945
Pubmed	NFI-B3, a novel transcriptional repressor of the nuclear factor I family, is generated by alternative RNA processing.	NFIB NFIC NFIX	3.62e-08	3	116	3	9099724
Pubmed	Nfix regulates fetal-specific transcription in developing skeletal muscle.	NFIA NFIB NFIC NFIX	3.81e-08	11	116	4	20178747
Pubmed	Nuclear factor I coordinates multiple phases of cerebellar granule cell development via regulation of cell adhesion molecules.	NFIA NFIB NFIC NFIX	8.21e-08	13	116	4	17553984
Pubmed	Differential neuronal and glial expression of nuclear factor I proteins in the cerebral cortex of adult mice.	NFIA NFIB NFIX	1.44e-07	4	116	3	28295292
Pubmed	Gene regulatory networks controlling vertebrate retinal regeneration.	NFIA NFIB NFIX	1.44e-07	4	116	3	33004674
Pubmed	RFX1 and NF-1 associate with P sequences of the human growth hormone locus in pituitary chromatin.	NFIB NFIC NFIX	1.44e-07	4	116	3	12624117
Pubmed	Exon structure of the nuclear factor I DNA-binding domain from C. elegans to mammals.	NFIA NFIB NFIC NFIX	2.07e-07	16	116	4	10087299
Pubmed	Selective control of type I IFN induction by the Rac activator DOCK2 during TLR-mediated plasmacytoid dendritic cell activation.	DOCK2 TLR7 TLR9	3.60e-07	5	116	3	20231379
Pubmed	Control of neurogenic competence in mammalian hypothalamic tanycytes.	NFIA NFIB NFIX	3.60e-07	5	116	3	34049878
Pubmed	Absence of the transcription factor Nfib delays the formation of the basilar pontine and other mossy fiber nuclei.	NFIA NFIB NFIX	7.18e-07	6	116	3	19107796
Pubmed	Expansion of the lateral ventricles and ependymal deficits underlie the hydrocephalus evident in mice lacking the transcription factor NFIX.	NFIA NFIB NFIX	2.00e-06	8	116	3	25960350
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	PITPNM2 RASA2 MID2 MYO9A ASH1L HECTD4 NAIP RNF213 DDX56 EFNA1 NFIA NFIB NFIC NFIX SCARB1 AUTS2 IFT122 DOCK6	2.20e-06	1489	116	18	28611215
Pubmed	The transcription factor gene Nfib is essential for both lung maturation and brain development.	NFIA NFIB NFIC NFIX	3.01e-06	30	116	4	15632069
Pubmed	MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons.	PDS5B ARRDC5 UTP14A HECTD4 DDX56 GPATCH8 EPB41L3 SDAD1 NKRF GPC4 ABCD3 PCDH15 SIPA1L2 DOCK6 SYMPK	3.30e-06	1082	116	15	38697112
Pubmed	Systematic bromodomain protein screens identify homologous recombination and R-loop suppression pathways involved in genome integrity.	IFT140 C5orf22 ASH1L PEX6 RNF213 DDX56 EPB41L3 ABCA7 NKRF CDKAL1 TRIM66 NUP188 WDFY3 SIPA1L2 TCF7L1	4.79e-06	1116	116	15	31753913
Pubmed	A genome-wide association study of seasonal pattern mania identifies NF1A as a possible susceptibility gene for bipolar disorder.	NFIA NFIX AUTS2	5.85e-06	11	116	3	22925353
Pubmed	Mast cell-dependent anorexia and hypothermia induced by mucosal activation of Toll-like receptor 7.	TLR7 TLR9 PTGS1	1.01e-05	13	116	3	18480244
Pubmed	Transcriptional regulation of Nfix by NFIB drives astrocytic maturation within the developing spinal cord.	NFIA NFIB NFIX	1.01e-05	13	116	3	29106906
Pubmed	Expression of toll-like receptors in HPV-positive and HPV-negative oropharyngeal squamous cell carcinoma--an in vivo and in vitro study.	TLR7 TLR9	1.10e-05	2	116	2	25941114
Pubmed	Novel small molecule inhibitors of TLR7 and TLR9: mechanism of action and efficacy in vivo.	TLR7 TLR9	1.10e-05	2	116	2	24342772
Pubmed	The Role of TLR7 and TLR9 in the Pathogenesis of Systemic Sclerosis.	TLR7 TLR9	1.10e-05	2	116	2	38892317
Pubmed	Polymorphisms in Toll-Like Receptors (TLRs)-7 and 9 Genes in Indian Population with Progressive and Nonprogressive HIV-1 Infection.	TLR7 TLR9	1.10e-05	2	116	2	30793925
Pubmed	Blocking toll-like receptors 7 and 9 reduces postinterventional remodeling via reduced macrophage activation, foam cell formation, and migration.	TLR7 TLR9	1.10e-05	2	116	2	22628437
Pubmed	Nucleic Acid-Targeting Pathways Promote Inflammation in Obesity-Related Insulin Resistance.	TLR7 TLR9	1.10e-05	2	116	2	27373163
Pubmed	Human plasmacytoid dendritic cells mount a distinct antiviral response to virus-infected cells.	TLR7 TLR9	1.10e-05	2	116	2	33811059
Pubmed	Effects of Single-Nucleotide Polymorphisms in the TLR7 and TLR9 Genes of Asthmatic Children.	TLR7 TLR9	1.10e-05	2	116	2	30373864
Pubmed	Nuclear Factor IA Is Down-regulated in Muscle-invasive and High-grade Bladder Cancers.	NFIA NFIB	1.10e-05	2	116	2	34969759
Pubmed	Single nucleotide polymorphisms of toll-like receptor 7 and toll-like receptor 9 in hepatitis C virus infection patients from central China.	TLR7 TLR9	1.10e-05	2	116	2	24532514
Pubmed	Sex bias in susceptibility to MCMV infection: implication of TLR9.	TLR7 TLR9	1.10e-05	2	116	2	23028824
Pubmed	The Role of the Oxidative State and Innate Immunity Mediated by TLR7 and TLR9 in Lupus Nephritis.	TLR7 TLR9	1.10e-05	2	116	2	37894915
Pubmed	Critical role of TLR7 in the acceleration of systemic lupus erythematosus in TLR9-deficient mice.	TLR7 TLR9	1.10e-05	2	116	2	19944565
Pubmed	Emerging roles of TLR7 and TLR9 in murine SLE.	TLR7 TLR9	1.10e-05	2	116	2	19846276
Pubmed	Increased expression of Toll-like receptors 7 and 9 in myasthenia gravis thymus characterized by active Epstein-Barr virus infection.	TLR7 TLR9	1.10e-05	2	116	2	26723518
Pubmed	Differences in codon bias and GC content contribute to the balanced expression of TLR7 and TLR9.	TLR7 TLR9	1.10e-05	2	116	2	26903634
Pubmed	Effect of toll-like receptor 7 and 9 targeted therapy to prevent the development of hepatocellular carcinoma.	TLR7 TLR9	1.10e-05	2	116	2	24990399
Pubmed	Association of single-nucleotide polymorphisms in TLR7 (Gln11Leu) and TLR9 (1635A/G) with a higher CD4T cell count during HIV infection.	TLR7 TLR9	1.10e-05	2	116	2	24747071
Pubmed	Toll-like receptor (TLR) 7 decreases and TLR9 increases the airway responses in mice with established allergic inflammation.	TLR7 TLR9	1.10e-05	2	116	2	24041926
Pubmed	Opposing impact of B cell-intrinsic TLR7 and TLR9 signals on autoantibody repertoire and systemic inflammation.	TLR7 TLR9	1.10e-05	2	116	2	24711620
Pubmed	Human Plasmacytoid Dendritic Cells and Cutaneous Melanoma.	TLR7 TLR9	1.10e-05	2	116	2	32054102
Pubmed	Necrotizing lymphadenitis may be induced by overexpression of Toll-like receptor7 (TLR7) caused by reduced TLR9 transport in plasmacytoid dendritic cells (PDCs).	TLR7 TLR9	1.10e-05	2	116	2	33994431
Pubmed	Overexpression of TLR7 and TLR9 Occurs Before Onset Symptoms In First-Degree Relatives of Rheumatoid Arthritis Patients.	TLR7 TLR9	1.10e-05	2	116	2	34272096
Pubmed	Cofactors required for TLR7- and TLR9-dependent innate immune responses.	TLR7 TLR9	1.10e-05	2	116	2	22423970
Pubmed	Hyper-responsive Toll-like receptor 7 and 9 activation in NADPH oxidase-deficient B lymphoblasts.	TLR7 TLR9	1.10e-05	2	116	2	26340429
Pubmed	Involvement of chondroitin sulfate synthase-3 (chondroitin synthase-2) in chondroitin polymerization through its interaction with chondroitin synthase-1 or chondroitin-polymerizing factor.	CHSY3 CHPF	1.10e-05	2	116	2	17253960
Pubmed	Increased expression of TLR7 and TLR9 in alopecia areata.	TLR7 TLR9	1.10e-05	2	116	2	31571275
Pubmed	Up-regulation of Toll-like receptors 7 and 9 and its potential implications in the pathogenic mechanisms of LMNA-related myopathies.	TLR7 TLR9	1.10e-05	2	116	2	29895224
Pubmed	Impact of TLR7 and TLR9 polymorphisms on susceptibility to placental infections and pregnancy complications.	TLR7 TLR9	1.10e-05	2	116	2	34102513
Pubmed	Expression of NFIA and NFIB within the murine spinal cord.	NFIA NFIB	1.10e-05	2	116	2	32068188
Pubmed	Impact of TLR9 and TLR7 gene polymorphisms on prognosis and survival of patients with oral squamous cell carcinoma.	TLR7 TLR9	1.10e-05	2	116	2	38850110
Pubmed	TLR9 signalling in microglia attenuates seizure-induced aberrant neurogenesis in the adult hippocampus.	TLR7 TLR9	1.10e-05	2	116	2	25751136
Pubmed	Divergent TLR7 and TLR9 signaling and type I interferon production distinguish pathogenic and nonpathogenic AIDS virus infections.	TLR7 TLR9	1.10e-05	2	116	2	18806803
Pubmed	Chronic TLR7 and TLR9 signaling drives anemia via differentiation of specialized hemophagocytes.	TLR7 TLR9	1.10e-05	2	116	2	30630901
Pubmed	Recognition of Borrelia burgdorferi, the Lyme disease spirochete, by TLR7 and TLR9 induces a type I IFN response by human immune cells.	TLR7 TLR9	1.10e-05	2	116	2	19794067
Pubmed	Toll-like receptor control of glucocorticoid-induced apoptosis in human plasmacytoid predendritic cells (pDCs).	TLR7 TLR9	1.10e-05	2	116	2	20592251
Pubmed	Heterogeneous functional effects of concomitant B cell receptor and TLR stimulation in chronic lymphocytic leukemia with mutated versus unmutated Ig genes.	TLR7 TLR9	1.10e-05	2	116	2	24719462
Pubmed	A GpC-rich oligonucleotide acts on plasmacytoid dendritic cells to promote immune suppression.	TLR7 TLR9	1.10e-05	2	116	2	22844124
Pubmed	Single Cell Based Phosphorylation Profiling Identifies Alterations in Toll-Like Receptor 7 and 9 Signaling in Patients With Primary Sjögren's Syndrome.	TLR7 TLR9	1.10e-05	2	116	2	30846988
Pubmed	Toll-like receptors 7 and 9 in myasthenia gravis thymus: amplifiers of autoimmunity?	TLR7 TLR9	1.10e-05	2	116	2	29363775
Pubmed	Nuclear Factor I A and Nuclear Factor I B Are Jointly Required for Mouse Postnatal Neural Stem Cell Self-Renewal.	NFIA NFIB	1.10e-05	2	116	2	38366751
Pubmed	Role of atopic status in Toll-like receptor (TLR)7- and TLR9-mediated activation of human eosinophils.	TLR7 TLR9	1.10e-05	2	116	2	19129482
Pubmed	Toll-like receptor 7 and 9 expression in peripheral blood mononuclear cells from patients with chronic hepatitis B and related hepatocellular carcinoma.	TLR7 TLR9	1.10e-05	2	116	2	18215354
Pubmed	Cell-intrinsic expression of TLR9 in autoreactive B cells constrains BCR/TLR7-dependent responses.	TLR7 TLR9	1.10e-05	2	116	2	25681333
Pubmed	Distinct autoantibody profiles in systemic lupus erythematosus patients are selectively associated with TLR7 and TLR9 upregulation.	TLR7 TLR9	1.10e-05	2	116	2	23564191
Pubmed	Transcriptional diversity during lineage commitment of human blood progenitors.	NFIB NFIC	1.10e-05	2	116	2	25258084
Pubmed	Inhibition of TLR7 and TLR9 Reduces Human Cholangiocarcinoma Cell Proliferation and Tumor Development.	TLR7 TLR9	1.10e-05	2	116	2	33939146
Pubmed	Identification of Thiostrepton as a Novel Inhibitor for Psoriasis-like Inflammation Induced by TLR7-9.	TLR7 TLR9	1.10e-05	2	116	2	26371257
Pubmed	TLR7 and TLR9 trigger distinct neuroinflammatory responses in the CNS.	TLR7 TLR9	1.10e-05	2	116	2	21801870
Pubmed	Contribution of TLR7 and TLR9 signaling to the susceptibility of MyD88-deficient mice to myocarditis.	TLR7 TLR9	1.10e-05	2	116	2	20187710
Pubmed	Prognostic significance of NFIA and NFIB in esophageal squamous carcinoma and esophagogastric junction adenocarcinoma.	NFIA NFIB	1.10e-05	2	116	2	29577671
Pubmed	Increased expression of endosomal members of toll-like receptor family abrogates wound healing in patients with type 2 diabetes mellitus.	TLR7 TLR9	1.10e-05	2	116	2	25586463
Pubmed	Expression of Toll-like receptor -7 and -9 in B cell subsets from patients with primary Sjögren's syndrome.	TLR7 TLR9	1.10e-05	2	116	2	25790192
Pubmed	TLR recognition of self nucleic acids hampers glucocorticoid activity in lupus.	TLR7 TLR9	1.10e-05	2	116	2	20559388
Pubmed	Transcription factors NFIA and NFIB induce cellular differentiation in high-grade astrocytoma.	NFIA NFIB	1.10e-05	2	116	2	31760595
Pubmed	Nucleic acids of mammalian origin can act as endogenous ligands for Toll-like receptors and may promote systemic lupus erythematosus.	TLR7 TLR9	1.10e-05	2	116	2	16230478
Pubmed	Integrative predictive model of coronary artery calcification in atherosclerosis.	APOB TLR7 TLR9 PTGS1 CAPN10 SCARB1 PLAT	1.24e-05	229	116	7	19948975
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	PITPNM2 HECTD4 PEX6 DDX56 ABCA7 SSH1 SCARB1 NUP188 WDFY3 MAPKBP1 SIPA1L2 CHPF DOCK6 SYMPK	1.96e-05	1105	116	14	35748872
Pubmed	A genome-wide screen for spatially restricted expression patterns identifies transcription factors that regulate glial development.	NFIA NFIB NFIX SIX5 TCF7L1	2.44e-05	102	116	5	19741146
Pubmed	Dual or triple activation of TLR7, TLR8, and/or TLR9 by single-stranded oligoribonucleotides.	TLR7 TLR9	3.30e-05	3	116	2	22196370
Pubmed	Toll-like receptors as adjuvant receptors.	TLR7 TLR9	3.30e-05	3	116	2	11909637
Pubmed	Expression of hepatocyte growth factor/scatter factor, its receptor, c-met, and tissue-type plasminogen activator during development of the murine olfactory system.	MET PLAT	3.30e-05	3	116	2	8824331
Pubmed	Single nucleotide polymorphisms in genes encoding toll-like receptors 7, 8 and 9 in Danish patients with systemic lupus erythematosus.	TLR7 TLR9	3.30e-05	3	116	2	24919757
Pubmed	Overall Status of Epstein-Barr virus Infection, IFN-a, and TLR-7/9 in Patients with Systemic Lupus Erythematous.	TLR7 TLR9	3.30e-05	3	116	2	34596588
Pubmed	Expression of toll-like receptors 3, 7, and 9 in peripheral blood mononuclear cells from patients with systemic lupus erythematosus.	TLR7 TLR9	3.30e-05	3	116	2	24692849
Pubmed	Toll-like receptor 7/8 (TLR7/8) and TLR9 agonists cooperate to enhance HIV-1 envelope antibody responses in rhesus macaques.	TLR7 TLR9	3.30e-05	3	116	2	24390332
Pubmed	Pitpnm1 is expressed in hair cells during development but is not required for hearing.	PITPNM2 PITPNM3	3.30e-05	3	116	2	23820044
Pubmed	Toll-like receptors 7, 8, and 9 expression and function in primary human cervical cancer Langerhans cells: evidence of anergy.	TLR7 TLR9	3.30e-05	3	116	2	23221735
Pubmed	Toll-like receptor 7 and TLR9 dictate autoantibody specificity and have opposing inflammatory and regulatory roles in a murine model of lupus.	TLR7 TLR9	3.30e-05	3	116	2	16973389
Pubmed	Autoimmune skin inflammation is dependent on plasmacytoid dendritic cell activation by nucleic acids via TLR7 and TLR9.	TLR7 TLR9	3.30e-05	3	116	2	21115693
Pubmed	Activation of NF-κB via endosomal Toll-like receptor 7 (TLR7) or TLR9 suppresses murine herpesvirus 68 reactivation.	TLR7 TLR9	3.30e-05	3	116	2	24942583
GeneFamily	Phosphatidylinositol transfer proteins	PITPNM2 PITPNM3	2.73e-04	6	78	2	1151
GeneFamily	CD molecules\|Toll like receptors	TLR7 TLR9	8.09e-04	10	78	2	948
GeneFamily	Pleckstrin homology domain containing\|SH2 domain containing\|C2 and RasGAP domain containing	RASA2 RASAL2	8.09e-04	10	78	2	830
GeneFamily	C2 domain containing\|Calpains	CAPN10 ADGB	1.86e-03	15	78	2	975
GeneFamily	Beta 4-glycosyltransferases	CHSY3 CHPF	2.40e-03	17	78	2	425
GeneFamily	G-patch domain containing\|Minor histocompatibility antigens	GPATCH8 NKRF	4.01e-03	22	78	2	579
GeneFamily	Intraflagellar transport proteins\|Tetratricopeptide repeat domain containing	IFT140 IFT122	4.77e-03	24	78	2	615
GeneFamily	Beta 3-glycosyltransferases	CHSY3 CHPF	4.77e-03	24	78	2	426
GeneFamily	WD repeat domain containing	IFT140 PAFAH1B1 IFT122 WDFY3 MAPKBP1	5.50e-03	262	78	5	362
GeneFamily	Cyclins	CCNO CCNI	6.46e-03	28	78	2	473
Coexpression	LAKE_ADULT_KIDNEY_C4_PROXIMAL_TUBULE_EPITHELIAL_CELLS_S2	KANSL1L RNF213 CDKAL1 ACSM3 MAST4 NFIA NFIB WDFY3 RASAL2	6.86e-08	176	112	9	M39223
Coexpression	LAKE_ADULT_KIDNEY_C3_PROXIMAL_TUBULE_EPITHELIAL_CELLS_S1_S2	KANSL1L ASH1L EPB41L3 MAST4 NFIA NFIB PCDH15 WDFY3	5.04e-06	221	112	8	M39222
CoexpressionAtlas	dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_k-means-cluster#1_top-relative-expression-ranked_500	MYO9A RNF213 SLC7A2 NFIA GPC4 TNS3	1.34e-05	99	111	6	gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_k1_500
CoexpressionAtlas	dev gonad_e13.5_M_SertoliCell_Sox9_k-means-cluster#2_top-relative-expression-ranked_1000	RNF213 ACSM3 NFIA GPC4 NXF3 ABCD3 AUTS2 TNS3	1.43e-05	209	111	8	gudmap_dev gonad_e13.5_M_SertoliCell_Sox9_k2_1000
CoexpressionAtlas	FacebaseRNAseq_e9.5_Olfactory Placode_top-relative-expression-ranked_2500_k-means-cluster#2	KANSL1L HECTD4 SAXO2 RNF213 EPB41L3 PTGS1 FREM1 SLC7A2 NFIB NFIC NFIX TNS3 FHIP2B	3.81e-05	655	111	13	Facebase_RNAseq_e9.5_Olfactory Placode_2500_K2
CoexpressionAtlas	dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_k-means-cluster#3_top-relative-expression-ranked_1000	MYO9A RNF213 SLC7A2 ACSM3 NFIA GPC4 TNS3	6.59e-05	191	111	7	gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_k3_1000
CoexpressionAtlas	DevelopingGonad_e16.5_ovary_emap-9563_top-relative-expression-ranked_1000	DOCK2 LETM2 MYO9A ASH1L RNF213 TRIM66 MAST4 NFIA NFIB PAFAH1B1 LEPROT WDFY3 RASAL2 FHIP2B	6.90e-05	795	111	14	gudmap_developingGonad_e16.5_ovary_1000
CoexpressionAtlas	dev gonad_e13.5_F_SupCellPrec_Sry_top-relative-expression-ranked_500	DOCK2 MYO9A RNF213 SLC7A2 EFNA1 ACSM3 NFIA GPC4 ZNF791 TNS3	7.46e-05	422	111	10	gudmap_dev gonad_e13.5_F_SupCellPrec_Sry_500
CoexpressionAtlas	dev gonad_e11.5_M_SupCellPrec_Sry_top-relative-expression-ranked_500	MYO9A RNF213 SLC7A2 ACSM3 NFIA GPC4 NXF3 ABCD3 PLAT TNS3	9.06e-05	432	111	10	gudmap_dev gonad_e11.5_M_SupCellPrec_Sry_500
CoexpressionAtlas	dev gonad_e12.5_M_SertoliCell_Sox9_k-means-cluster#2_top-relative-expression-ranked_1000	RNF213 ACSM3 NFIA GPC4 NXF3 ABCD3 TNS3	9.95e-05	204	111	7	gudmap_dev gonad_e12.5_M_SertoliCell_Sox9_k2_1000
CoexpressionAtlas	dev gonad_e12.5_F_SupCellPrec_Sry_k-means-cluster#1_top-relative-expression-ranked_500	MYO9A RNF213 SLC7A2 GPC4 NXF3 TNS3	1.15e-04	145	111	6	gudmap_dev gonad_e12.5_F_SupCellPrec_Sry_k1_500
CoexpressionAtlas	dev gonad_e12.5_F_VasAssMesen_MafB_k-means-cluster#1_top-relative-expression-ranked_500	MYO9A RNF213 SLC7A2 NFIA TNS3	1.16e-04	91	111	5	gudmap_dev gonad_e12.5_F_VasAssMesen_MafB_k1_500
CoexpressionAtlas	dev gonad_e12.5_F_VasAssMesen_MafB_k-means-cluster#4_top-relative-expression-ranked_200	MYO9A RNF213 SLC7A2 TNS3	1.58e-04	52	111	4	gudmap_dev gonad_e12.5_F_VasAssMesen_MafB_k4_200
CoexpressionAtlas	dev gonad_e13.5_F_SupCellPrec_Sry_k-means-cluster#2_top-relative-expression-ranked_1000	MYO9A RNF213 SLC7A2 NFIA GPC4 NXF3 TNS3	1.73e-04	223	111	7	gudmap_dev gonad_e13.5_F_SupCellPrec_Sry_k2_1000
CoexpressionAtlas	FacebaseRNAseq_e8.5_Non-Floor Plate Neural Epithelium_top-relative-expression-ranked_1000_k-means-cluster#4	RNF213 PTGS1 SLC7A2 NFIA NFIB NFIC NFIX PCDH15	1.73e-04	298	111	8	Facebase_RNAseq_e8.5_Non-Floor Plate Neural Epithelium_1000_K4
CoexpressionAtlas	dev gonad_e12.5_F_VasAssMesen_MafB_k-means-cluster#4_top-relative-expression-ranked_1000	MYO9A RNF213 SLC7A2 NFIA GPC4 NXF3 ZNF791 TNS3	1.86e-04	301	111	8	gudmap_dev gonad_e12.5_F_VasAssMesen_MafB_k4_1000
CoexpressionAtlas	FacebaseRNAseq_e9.5_Facial Mesenchyne_top-relative-expression-ranked_1000_k-means-cluster#3	SAXO2 RNF213 PTGS1 SLC7A2 NFIA NFIB NFIC NFIX PCDH15	1.88e-04	384	111	9	Facebase_RNAseq_e9.5_Facial Mesenchyne_1000_K3
CoexpressionAtlas	FacebaseRNAseq_e8.5_Non-Floor Plate Neural Epithelium_top-relative-expression-ranked_2500_k-means-cluster#1	KANSL1L SAXO2 RNF213 EPB41L3 PTGS1 FREM1 GPR179 SLC7A2 EFNA1 NFIA NFIC NFIX PCDH15 TNS3	1.95e-04	878	111	14	Facebase_RNAseq_e8.5_Non-Floor Plate Neural Epithelium_2500_K1
CoexpressionAtlas	dev gonad_e13.5_F_SupCellPrec_Sry_k-means-cluster#2_top-relative-expression-ranked_200	RNF213 ACSM3 TNS3	2.28e-04	23	111	3	gudmap_dev gonad_e13.5_F_SupCellPrec_Sry_k2_200
CoexpressionAtlas	dev gonad_e11.5_M_SupCellPrec_Sry_k-means-cluster#2_top-relative-expression-ranked_500	MYO9A RNF213 SLC7A2 NFIA NXF3 TNS3	2.56e-04	168	111	6	gudmap_dev gonad_e11.5_M_SupCellPrec_Sry_k2_500
CoexpressionAtlas	Myeloid Cells, MF.RP.Sp, F4/80hi CD11blo CD11c- autofluorescent, Spleen, avg-3	MYO9A TLR7 EPB41L3 PTGS1 SLC7A2 SCARB1 WDFY3 HS3ST2 TNS3	2.68e-04	403	111	9	GSM605853_500
CoexpressionAtlas	FacebaseRNAseq_ratio_e10.5_MandibularArch_vs_MaxillaryArch_top-relative-expression-ranked_2500_k-means-cluster#4	KANSL1L SAXO2 RNF213 EPB41L3 PTGS1 FREM1 SLC7A2 NFIB NFIC NFIX TNS3	2.71e-04	591	111	11	Facebase_RNAseq_ratio_e10.5_MandibularArch_vs_MaxillaryArch_2500_K4
CoexpressionAtlas	dev gonad_e12.5_F_SupCellPrec_Sry_top-relative-expression-ranked_1000	DOCK2 ACADL MYO9A HECTD4 RNF213 SLC7A2 EFNA1 ACSM3 NFIA GPC4 NXF3 ZNF791 TNS3	2.90e-04	803	111	13	gudmap_dev gonad_e12.5_F_SupCellPrec_Sry_1000
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_2500_k-means-cluster#2	MID2 SAXO2 RNF213 EPB41L3 PTGS1 FREM1 SLC7A2 NFIB NFIC NFIX TNS3	2.91e-04	596	111	11	Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_2500_K2
CoexpressionAtlas	dev gonad_e12.5_F_SupCellPrec_Sry_top-relative-expression-ranked_500	DOCK2 ACADL MYO9A RNF213 SLC7A2 NFIA GPC4 NXF3 TNS3	3.27e-04	414	111	9	gudmap_dev gonad_e12.5_F_SupCellPrec_Sry_500
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_2500_k-means-cluster#2	KANSL1L HECTD4 RNF213 EPB41L3 PTGS1 FREM1 SLC7A2 NFIB NFIC NFIX TNS3	3.40e-04	607	111	11	Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_2500_K2
CoexpressionAtlas	dev gonad_e12.5_M_InterstitLeydig_MafB_k-means-cluster#2_top-relative-expression-ranked_1000	RNF213 SLC7A2 NFIA GPC4 ZNF791	3.90e-04	118	111	5	gudmap_dev gonad_e12.5_M_InterstitLeydig_MafB_k2_1000
CoexpressionAtlas	FacebaseRNAseq_e8.5_Paraxial Mesoderm_top-relative-expression-ranked_2500_k-means-cluster#4	KANSL1L SAXO2 RNF213 EPB41L3 PTGS1 FREM1 SLC7A2 NFIB NFIC NFIX IFT122 TNS3	4.43e-04	731	111	12	Facebase_RNAseq_e8.5_Paraxial Mesoderm_2500_K4
CoexpressionAtlas	FacebaseRNAseq_ratio_e9.5_MandibularArch_vs_MaxillaryArch_top-relative-expression-ranked_2500_k-means-cluster#5	KANSL1L SAXO2 RNF213 EPB41L3 PTGS1 FREM1 SLC7A2 NFIB NFIC NFIX IFT122 TNS3	4.60e-04	734	111	12	Facebase_RNAseq_ratio_e9.5_MandibularArch_vs_MaxillaryArch_2500_K5
CoexpressionAtlas	dev gonad_e11.5_M_SupCellPrec_Sry_k-means-cluster#3_top-relative-expression-ranked_500	RNF213 ACSM3 GPC4 ABCD3 PLAT	4.72e-04	123	111	5	gudmap_dev gonad_e11.5_M_SupCellPrec_Sry_k3_500
CoexpressionAtlas	FacebaseRNAseq_ratio_e9.5_MaxillaryArch_vs_Mandibular_top-relative-expression-ranked_1000_k-means-cluster#1	SAXO2 RNF213 PTGS1 SLC7A2 NFIB NFIC NFIX	4.91e-04	265	111	7	Facebase_RNAseq_ratio_e9.5_MaxillaryArch_vs_Mandibular_1000_K1
CoexpressionAtlas	dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_top-relative-expression-ranked_1000	DOCK2 MYO9A RNF213 FREM1 SLC7A2 ACSM3 NFIA NFIB NFIX GPC4 PALLD TNS3	4.94e-04	740	111	12	gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_1000
CoexpressionAtlas	dev gonad_e13.5_M_InterstitFLeydig_MafB_k-means-cluster#1_top-relative-expression-ranked_1000	RNF213 SLC7A2 NFIA GPC4 TNS3	5.08e-04	125	111	5	gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_k1_1000
CoexpressionAtlas	FacebaseRNAseq_e9.5_Facial Mesenchyne_top-relative-expression-ranked_2500_k-means-cluster#2	KANSL1L RNF213 EPB41L3 FREM1 SLC7A2 NFIB NFIC NFIX IFT122 TNS3 FHIP2B	5.43e-04	642	111	11	Facebase_RNAseq_e9.5_Facial Mesenchyne_2500_K2
CoexpressionAtlas	dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_top-relative-expression-ranked_500	MYO9A RNF213 FREM1 SLC7A2 NFIA GPC4 PALLD TNS3	5.80e-04	357	111	8	gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_500
CoexpressionAtlas	FacebaseRNAseq_e10.5_Olfactory Pit_top-relative-expression-ranked_1000_k-means-cluster#5	RNF213 PTGS1 SLC7A2 NFIA NFIB NFIX PCDH15	6.25e-04	276	111	7	Facebase_RNAseq_e10.5_Olfactory Pit_1000_K5
CoexpressionAtlas	DevelopingGonad_e12.5_ovary_emap-28876_k-means-cluster#3_top-relative-expression-ranked_1000	ASH1L CDKAL1 MAST4 NFIB PAFAH1B1 WDFY3 FHIP2B	6.38e-04	277	111	7	gudmap_developingGonad_e12.5_ovary_k3_1000
CoexpressionAtlas	DevelopingGonad_e18.5_epididymis_emap-13166_k-means-cluster#3_top-relative-expression-ranked_1000	ASH1L CDKAL1 MAST4 NFIB PAFAH1B1 CHSY3 WDFY3	6.94e-04	281	111	7	gudmap_developingGonad_e18.5_epididymis_1000_k3
CoexpressionAtlas	DevelopingGonad_P2_epididymis_emap-30199_k-means-cluster#2_top-relative-expression-ranked_500	ASH1L MAST4 NFIB PAFAH1B1 WDFY3	7.45e-04	136	111	5	gudmap_developingGonad_P2_epididymis_500_k2
CoexpressionAtlas	FacebaseRNAseq_e9.5_Maxillary Arch_top-relative-expression-ranked_500_k-means-cluster#3	PTGS1 NFIA NFIB NFIX PCDH15	7.70e-04	137	111	5	Facebase_RNAseq_e9.5_Maxillary Arch_500_K3
CoexpressionAtlas	FacebaseRNAseq_e10.5_Olfactory Pit_top-relative-expression-ranked_2500_k-means-cluster#3	KANSL1L RNF213 EPB41L3 FREM1 SLC7A2 NFIB NFIC NFIX TNS3 FHIP2B	7.85e-04	567	111	10	Facebase_RNAseq_e10.5_Olfactory Pit_2500_K3
CoexpressionAtlas	Myeloid Cells, DC.8-4-11b-.Sp, CD45-APC CD11b-FITC CD11c-eFluor780 CD4-PE CD8a-eF, Spleen, avg-2	BCL2L14 HINT1 MYO9A TLR7 TLR9 MET RASAL2 TNS3	7.98e-04	375	111	8	GSM605837_500
CoexpressionAtlas	FacebaseRNAseq_ratio_e9.5_MandibularArch_vs_MaxillaryArch_top-relative-expression-ranked_1000_k-means-cluster#2	SAXO2 RNF213 PTGS1 SLC7A2 NFIB NFIC NFIX	8.35e-04	290	111	7	Facebase_RNAseq_ratio_e9.5_MandibularArch_vs_MaxillaryArch_1000_K2
CoexpressionAtlas	DevelopingGonad_P2_epididymis_emap-30199_k-means-cluster#5_top-relative-expression-ranked_1000	NFIA NFIB NFIC NFIX LEPROT	8.77e-04	141	111	5	gudmap_developingGonad_P2_epididymis_1000_k5
ToppCell	Neuron-Postmitotic-Excitatory_Neuron_-IPC/newborn-38\|World / Primary Cells by Cluster	HECTD4 NFIB NFIC NFIX AUTS2 LEPROT CCNI	8.35e-07	196	116	7	38da0751941adca650fe9b383d9f343153978eb5
ToppCell	Neuron-Postmitotic-Excitatory_Neuron_-IPC/newborn\|World / Primary Cells by Cluster	HECTD4 NFIB NFIC NFIX AUTS2 LEPROT CCNI	8.35e-07	196	116	7	721650a08d260faf530dbd52d4e9275d27f3bac2
ToppCell	Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	PITPNM2 TLR7 MET MAST4 AUTS2 CHSY3	5.60e-06	170	116	6	a2c738e441ced90eeeb1fcc6ca3269b918aaa298
ToppCell	LPS-IL1RA+antiTNF\|World / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	MYO9A EPB41L3 PTGS1 FREM1 EFNA1 NFIB	7.06e-06	177	116	6	b7fee75de7e96924af488a5baa2334711889ae7c
ToppCell	Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	MET EFNA1 MAST4 PITPNM3 AUTS2 CHSY3	7.29e-06	178	116	6	f5ed4a6e3eb8056b1be1fb311021710c95bdf888
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	MYO9A CDKAL1 MET GPC4 WDFY3 TNS3	8.54e-06	183	116	6	738e94b50c4c08c727d4eed0708dda08aa6891b4
ToppCell	E16.5-samps-Mesenchymal\|E16.5-samps / Age Group, Lineage, Cell class and subclass	FREM1 NFIA NFIB NFIX PALLD TNS3	9.96e-06	188	116	6	3f0f662be684e3a4c6652e636cc135a39a1d2790
ToppCell	COVID-19-Heart-EC_(POSTN)\|COVID-19 / Disease (COVID-19 only), tissue and cell type	PKHD1L1 PTGS1 NFIA NFIB PCDH15 HS3ST2	1.03e-05	189	116	6	7346c1112e2e155dbd71b6dbc80e680fd262a691
ToppCell	RA-10._Endothelium_II\|RA / Chamber and Cluster_Paper	PKHD1L1 PTGS1 NFIB PCDH15 HS3ST2 DOCK6	1.03e-05	189	116	6	c81787a8c662db5d7814c583dd64562857629e81
ToppCell	Control-Endothelial-VE_Venous\|Endothelial / Disease state, Lineage and Cell class	PTGS1 MET SLC7A2 MAST4 SSH1 PLAT	1.06e-05	190	116	6	4e30155203b4a8c5e496fcbe9348b67b98ebc625
ToppCell	COVID-19-kidney-VWF+PLVAP+EC\|COVID-19 / Disease (COVID-19 only), tissue and cell type	PITPNM2 PLAT SIPA1L2 DOCK6 TCF7L1 RASAL2	1.09e-05	191	116	6	2f00d0b7b2ffce8eb3eb5bbae49a0d425b23c982
ToppCell	COPD-Epithelial\|COPD / Disease state, Lineage and Cell class	SAXO2 MET SLC7A2 EFNA1 MAST4 NFIB	1.12e-05	192	116	6	0644fad5df18f0021f6f49cca996d8cf47f972ff
ToppCell	nucseq-Epithelial-Epithelial_Alveolar-AT2-AT2\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	ACADL MET SLC7A2 MAST4 AUTS2 TCF7L1	1.16e-05	193	116	6	fd4d3c0d7caf8a2fff5b3d901fc28d19a8163cdf
ToppCell	nucseq-Epithelial-Epithelial_Alveolar-AT2\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	ACADL MET SLC7A2 MAST4 AUTS2 TCF7L1	1.16e-05	193	116	6	f3cc7cfdbc164a4ed42f87647111522b7d393bcb
ToppCell	LPS-IL1RA-Endothelial-Endothelial-Gen_Cap\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	PITPNM2 MAST4 NFIB SIPA1L2 DOCK6 RASAL2	1.19e-05	194	116	6	0b9cd96fa0b616da7cc90e92ff71157e9bba518f
ToppCell	facs-GAT-Fat-18m-Mesenchymal-mesenchymal_progenitor\|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NFIA NFIB NFIC NFIX PLAT TCF7L1	1.19e-05	194	116	6	9709dc95fb6982b6a0467b507845d5bc17252e3e
ToppCell	facs-GAT-Fat-18m-Mesenchymal-mesenchymal_stem_cell_of_adipose\|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NFIA NFIB NFIC NFIX PLAT TCF7L1	1.19e-05	194	116	6	93b7a9065430740ec31fce4e8c14ffccb498591d
ToppCell	facs-GAT-Fat-18m-Mesenchymal\|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NFIA NFIB NFIC NFIX PLAT TCF7L1	1.19e-05	194	116	6	0d2e65b44e3f143971c2fd24c4552f042b049cfa
ToppCell	10x5'v1-week_12-13-Myeloid_neutrophil-granulo-eo/baso/mast-mast_cell\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	PTGS1 FREM1 MAST4 TLDC2 PLAT CCNI	1.30e-05	197	116	6	61f909737c5f630beffdd326c6844215643dbdde
ToppCell	Bronchial-NucSeq-Epithelial-Epi_alveolar-AT2\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	ACADL MET RNF220 MAST4 AUTS2 TCF7L1	1.34e-05	198	116	6	f948391296c261c473d339069a6d0f20ccd6f38f
ToppCell	10x5'v1-week_12-13-Myeloid_neutrophil-granulo-eo/baso/mast\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	PTGS1 FREM1 MAST4 TLDC2 PLAT CCNI	1.34e-05	198	116	6	a1247a5efd92f95c6227c0e71dc8a0427eb54b7f
ToppCell	LPS_IL1RA-Endothelial-Endothelial-Gen_Cap\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	PITPNM2 ASH1L RNF213 MAST4 NFIB DOCK6	1.41e-05	200	116	6	dccec522ab0d7fff62ad6273b02aa9022dbbb8eb
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Myeloid-Dendritic-plasmacytoid_dendritic_cell-DC_c4-LILRA4\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	EPB41L3 CREB3L4 PTGS1 CHPF MGAT5B	3.65e-05	143	116	5	d0ed8c25da1327085e042c2e03cb7503e2c52ce0
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Myeloid-Dendritic-plasmacytoid_dendritic_cell\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	EPB41L3 CREB3L4 PTGS1 CHPF MGAT5B	3.65e-05	143	116	5	8900b92a24289204b9ec7baccc11594fec7694f1
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	IFT140 ACSM3 GPC4 NXF3 SIPA1L2	4.17e-05	147	116	5	989a48bda98fbff398985397a6b1189a4cbc80e7
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	IFT140 ACSM3 GPC4 NXF3 SIPA1L2	4.17e-05	147	116	5	f6681c849c4c06154548bd29a094f202d1c946c2
ToppCell	Posterior_cortex-Neuronal-Inhibitory-iN2(Gad1Gad2)-Synpr-Inhibitory_Neuron.Gad1Gad2.Synpr-Sncg_(Neuron.Gad1Gad2.Synpr-Sncg)-\|Posterior_cortex / BrainAtlas - Mouse McCarroll V32	LARGE2 FREM1 GPR179 ECEL1	4.20e-05	74	116	4	216721986c3055f2d9b4702be9693b3a0892283c
ToppCell	Posterior_cortex-Neuronal-Inhibitory-iN2(Gad1Gad2)-Synpr-Inhibitory_Neuron.Gad1Gad2.Synpr-Sncg_(Neuron.Gad1Gad2.Synpr-Sncg)\|Posterior_cortex / BrainAtlas - Mouse McCarroll V32	LARGE2 FREM1 GPR179 ECEL1	4.20e-05	74	116	4	a7f7ed7316c226e18ee62d0149be7404326817c6
ToppCell	primary_visual_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Lmo1_Fam159b\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	DOCK2 ACADL GRPR FREM1 MGAT5B	4.44e-05	149	116	5	98ae408d2d0347865875ff8bbd89d359decea526
ToppCell	BAL-Severe-Myeloid-cDC-cDC-cDC_12\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	CHTF18 SIX5 MRPL38 TIMELESS IFT122	5.20e-05	154	116	5	3c9d38709f507e91ec3bcc6184cbbfa9b1250128
ToppCell	BAL-Severe-Myeloid-cDC-cDC-cDC_12\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	CHTF18 SIX5 MRPL38 TIMELESS IFT122	5.20e-05	154	116	5	1ad4152a3e4bf5912954235fe21c2447e99f3de7
ToppCell	Adult-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)\|Adult / Lineage, Cell type, age group and donor	PITPNM2 MET MAST4 PITPNM3 AUTS2	6.81e-05	163	116	5	e819a1d6d28290854aa0672b3a18fa9e293d8f23
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Degenerative_Descending_Thin_Limb_Cell_Type_3\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	MYO9A MET SLC7A2 GPC4 ECEL1	7.01e-05	164	116	5	1cb5fbd7050650047ad6f2ca792118e98d58d22b
ToppCell	5'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-tracheobronchial_goblet_cell\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	BCL2L14 CCNO CREB3L4 MET ZNF888	7.42e-05	166	116	5	60060b03f2abfa3cc08107ab5a9f578e60e4ae16
ToppCell	5'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-tracheobronchial_goblet_cell-Goblet_(subsegmental)\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	BCL2L14 CCNO CREB3L4 MET ZNF888	7.42e-05	166	116	5	ec9161d388db5a257b8d125c14f9dd911d5d5d4a
ToppCell	5'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-tracheobronchial_goblet_cell-Goblet_(subsegmental)-\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	BCL2L14 CCNO CREB3L4 MET ZNF888	7.42e-05	166	116	5	4586d6725403f879fc96f67be579022587ce1906
ToppCell	Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D046\|Children_(3_yrs) / Lineage, Cell type, age group and donor	BCL2L14 MET MAST4 GPC4 CHSY3	7.42e-05	166	116	5	c20479fe7a4306320d7f26e78bf956225f00f35a
ToppCell	5'-Airway_Nasal-Immune_Myeloid-Myeloid_macrophage\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	NAIP TLR7 EPB41L3 PTGS1 HS3ST2	7.63e-05	167	116	5	2dc3de562a26077cb76855b725cf278a272d3276
ToppCell	saliva-Severe-critical_progression_d28-40-Lymphocytic-Lymphocytic_B-B_cell-B_c01-TCL1A\|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k)	ADGB NFIB GPC4 SIX5 IFT122	7.85e-05	168	116	5	9a8709d34865cfa668d8f3335dc34fc86fc32482
ToppCell	15-Airway-Epithelial-Club-like_secretory\|Airway / Age, Tissue, Lineage and Cell class	ACADL CCNO MET TRIM66 PITPNM3	8.30e-05	170	116	5	1418031cc4b4a87a48621eb53a3c819cd713ddd0
ToppCell	Club-club-3\|World / Class top	TLR7 TLR9 PKHD1L1 NFIA PLAT	8.77e-05	172	116	5	34fbb82a2ec77dd183cf26b38edeb7e936b707bc
ToppCell	10x3'2.3-week_12-13-Myeloid_neutrophil-granulo-eo/baso/mast-eosinophil\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	PTGS1 TLDC2 PLAT ECEL1 CCNI	9.01e-05	173	116	5	1e4afa020fae682521335b440ccd33c16f37156f
ToppCell	droplet-Liver-LIVER_HEP-30m-Myeloid-Kupffer_cell\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYO9A CREB3L4 PTGS1 ADGB WDFY3	9.77e-05	176	116	5	5e46a09a36b9645b1b1fcb0b64bd0898561af3a9
ToppCell	Control\|World / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	KANSL1L NFIA CHSY3 TCF7L1 RASAL2	1.00e-04	177	116	5	b8ff6940e31b749776e81ae4f5bbd577dba9749c
ToppCell	10x5'-GI_large-bowel-Mast\|GI_large-bowel / Manually curated celltypes from each tissue	PTGS1 FREM1 TLDC2 PITPNM3 PLAT	1.03e-04	178	116	5	d10ed2543c96e1a2373f847e0b82144771e26d07
ToppCell	10x5'-GI_large-bowel-Mast-Mast_cells\|GI_large-bowel / Manually curated celltypes from each tissue	PTGS1 FREM1 TLDC2 PITPNM3 PLAT	1.03e-04	178	116	5	8fc5f735afa25ae43c2acb1c710ade6e9e093e3c
ToppCell	Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)\|Children_(3_yrs) / Lineage, Cell type, age group and donor	BCL2L14 MET EFNA1 MAST4 CHSY3	1.06e-04	179	116	5	cb38b54261a7af5ee3347e64c8aa880a77ed0763
ToppCell	LPS_only-Epithelial_alveolar-AT_2-Differentiating_AT2\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	BCL2L14 MET RNF220 MAST4 AUTS2	1.06e-04	179	116	5	fd2cbee532e7b44113410dca82aec7db1a7fb69f
ToppCell	Fetal_29-31_weeks-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D088\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	PITPNM2 SCARB1 PLAT SIPA1L2 DOCK6	1.09e-04	180	116	5	d8ef44710a77ad0fc03243428e5e1dc4d41200cb
ToppCell	Control-Epithelial_cells-AT2\|Control / group, cell type (main and fine annotations)	ACADL SLC7A2 MAST4 AUTS2 TCF7L1	1.09e-04	180	116	5	198b19e7910b4a8cc7e820c525ab357c7f99f578
ToppCell	IIH-plasma\|IIH / Condition, Cell_class and T cell subcluster	ACADL SLC7A2 NFIB GPC4 CHSY3	1.11e-04	181	116	5	13d1f31bcbac21aea91de74f51eed549ec61003e
ToppCell	IIH-plasma-\|IIH / Condition, Cell_class and T cell subcluster	ACADL SLC7A2 NFIB GPC4 CHSY3	1.11e-04	181	116	5	140ac43dc6b89396872f908c14c89278f6d982b2
ToppCell	PND07-28-samps-Endothelial-Postnatal_endothelial-capillary_endothelial_Hpgd-CA4_high\|PND07-28-samps / Age Group, Lineage, Cell class and subclass	EFNA1 SCARB1 TIMELESS DOCK6 RASAL2	1.11e-04	181	116	5	9cd5e5c285c2b628db9d59709af053defd7c0aff
ToppCell	facs-Brain_Non-Myeloid-Cortex-24m-Mesenchymal\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SLC6A17 SIX5 DOCK6 PALLD TCF7L1	1.14e-04	182	116	5	ffe500d78a89dc6b4d05bab1664e7f30c94fb8d9
ToppCell	COPD-Epithelial-ATII\|World / Disease state, Lineage and Cell class	ACADL MET SLC7A2 MAST4 AUTS2	1.17e-04	183	116	5	8e9aab4eeec2e282c2cab9bfca6dbf40d660c7b9
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	MYO9A MET GPC4 WDFY3 TNS3	1.17e-04	183	116	5	92fbd83a9d13ee91065cbd479fb298f1fd564568
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SLC6A17 APOB PKHD1L1 FREM1 PCDH15	1.20e-04	184	116	5	2cbed6462fea2622871bb7e49b0df3d984239281
ToppCell	facs-Brain_Non-Myeloid-Cortex-24m-Mesenchymal-Pericyte\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SLC6A17 SIX5 DOCK6 PALLD TCF7L1	1.20e-04	184	116	5	94748f63947db79a6b4540e3090a63689fdd9452
ToppCell	facs-Brain_Non-Myeloid-Cortex-24m-Mesenchymal-brain_pericyte\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SLC6A17 SIX5 DOCK6 PALLD TCF7L1	1.20e-04	184	116	5	819b277ecced7b415e363c7e7ddbc6f3b2d296de
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SLC6A17 APOB PKHD1L1 FREM1 PCDH15	1.20e-04	184	116	5	ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SLC6A17 APOB PKHD1L1 FREM1 PCDH15	1.20e-04	184	116	5	2b19a8c5f823e00812908b23e66bb4e563278aff
ToppCell	Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)\|Children_(3_yrs) / Lineage, Cell type, age group and donor	MET MAST4 PITPNM3 AUTS2 CHSY3	1.23e-04	185	116	5	98b8ee42b89d97e4c9db01740e0c193503c68f2c
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	ACSM3 MAST4 NFIA NFIB GPC4	1.27e-04	186	116	5	b87acc80b7baa41681e4ed11d5537b9fbf5832f5
ToppCell	LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_2-Differentiating_AT2\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	BCL2L14 RNF220 MAST4 ABCD3 AUTS2	1.27e-04	186	116	5	e83718fabb057100835d3357df407f283d23fe16
ToppCell	LV-10._Endothelium_II\|World / Chamber and Cluster_Paper	PKHD1L1 PTGS1 PCDH15 HS3ST2 DOCK6	1.30e-04	187	116	5	7876dcb4800c2e54874df3d933efb79307a64a97
ToppCell	COVID-19-Endothelial_cells-Pulmonary_venous_endothelial_cells\|COVID-19 / group, cell type (main and fine annotations)	PKHD1L1 MET NFIB PLAT DOCK6	1.30e-04	187	116	5	2d20193a6cacdfa4877457c97b0077408942186c
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	KANSL1L ACSM3 NFIA NFIB WDFY3	1.30e-04	187	116	5	9d77ca45f7563bd6f2a0c1be5d99d93ad30983f7
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_PAX6\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	GRPR SLC7A2 ARSF PALLD TNS3	1.30e-04	187	116	5	d2ffb2f34f07b0dd5d3cb3ee0275f46ebecf4146
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	MYO9A CDKAL1 MET GPC4 TNS3	1.33e-04	188	116	5	63a4b25a0a6e05f80f1a6dd91b817f3cf49e6b68
ToppCell	E12.5-Mesenchymal\|E12.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	NFIA NFIB AUTS2 PLAT PALLD	1.33e-04	188	116	5	9778dadc2bd7ded3a723e717d1c8cd3160e99c6c
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	MYO9A CDKAL1 GPC4 WDFY3 TNS3	1.36e-04	189	116	5	904b8337e2cabac2f0bf5dad5598fc429581ed81
ToppCell	RA-10._Endothelium_II\|World / Chamber and Cluster_Paper	PKHD1L1 PTGS1 NFIB PCDH15 HS3ST2	1.36e-04	189	116	5	75c248b9de5e2fb7a0baa8cdbab516e575cc4394
ToppCell	E18.5-samps-Mesenchymal\|E18.5-samps / Age Group, Lineage, Cell class and subclass	FREM1 NFIA NFIB PALLD TNS3	1.36e-04	189	116	5	0c18d3de4720759cf802eefb4d0ddde2a9246a1a
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	EPB41L3 MAST4 NFIA NFIB PCDH15	1.43e-04	191	116	5	3c464645d0e7e423f791bd63bf5bcf11f6b590d3
ToppCell	E16.5-samps-Mesenchymal-Matrix_fibroblast-_fetal\|E16.5-samps / Age Group, Lineage, Cell class and subclass	FREM1 LCLAT1 NFIA PALLD TNS3	1.43e-04	191	116	5	3379d145d34f89150f7b06d1340022cfc6b4a6ce
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	EPB41L3 MAST4 NFIA NFIB PCDH15	1.43e-04	191	116	5	1c1d13144259b998d4a0e85142f7afef2ef1e63f
ToppCell	COVID-19-kidney-Stressed_EC\|kidney / Disease (COVID-19 only), tissue and cell type	ARID5A PLAT SIPA1L2 DOCK6 NPAS4	1.43e-04	191	116	5	d35aa842b813ea0eff7362abc894cca4e86b2fb2
ToppCell	COVID-19-Heart-EC_(POSTN)\|Heart / Disease (COVID-19 only), tissue and cell type	PKHD1L1 PTGS1 NFIB PCDH15 HS3ST2	1.47e-04	192	116	5	c0c34785a7bdf461722029b322e9184e3d9b3c26
ToppCell	facs-Heart-LA-3m-Endothelial-endothelial_cell_of_endocardium\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PKHD1L1 PTGS1 FREM1 EFNA1 DOCK6	1.47e-04	192	116	5	14a816ef116aa992f86edab411f043cf7d07fe04
ToppCell	facs-Liver-Liver_non-hepato/SCs_st-18m-Endothelial-nan\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PITPNM2 NFIA TCF7L1 RASAL2 TNS3	1.47e-04	192	116	5	6806a1a9fe00395dc1abc3e0124b4261dc701f31
ToppCell	Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D139\|Children_(3_yrs) / Lineage, Cell type, age group and donor	ACADL SLC7A2 MAST4 AUTS2 TCF7L1	1.47e-04	192	116	5	cc9911e182a289779a2612bc213daae5607689e7
ToppCell	Adult-Epithelial-alveolar_epithelial_cell_type_2-D122\|Adult / Lineage, Cell type, age group and donor	MET MAST4 GPC4 AUTS2 TCF7L1	1.47e-04	192	116	5	06013a07e3a873b1d1c0451643c528593ac32a9c
ToppCell	Smart-start-Cell-Wel_seq-Neoplastic-Differentiated-like-AC-like-AC-like_Prolif-G\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	GRPR MAST4 NFIA CHTF18 TIMELESS	1.47e-04	192	116	5	d6f656be2698bd215717d35f4e7ab727c08c61e0
ToppCell	facs-Heart-LA-3m-Endothelial-endocardial_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PKHD1L1 PTGS1 FREM1 EFNA1 DOCK6	1.47e-04	192	116	5	847822514d747a21d5eb40e04ba9a023fd32bd65
ToppCell	nucseq\|World / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	BCL2L14 EPB41L3 CDKAL1 RASAL2 TNS3	1.50e-04	193	116	5	779276e775cb2492e8dd36436295a536084a6415
ToppCell	facs-MAT-Fat-24m-Mesenchymal-mesenchymal_stem_cell_of_adipose\|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NFIA NFIB NFIC NFIX PLAT	1.50e-04	193	116	5	733f557bdc80293b40ccdf560f1675793df932d6
ToppCell	facs-MAT-Fat-24m-Mesenchymal\|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NFIA NFIB NFIC NFIX PLAT	1.50e-04	193	116	5	eb3c46b6fb06dc8708dc3032189b47ed93ee2357
ToppCell	facs-Trachea-18m-Mesenchymal-fibroblast\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	NFIA NFIB NFIX PLAT CHPF	1.50e-04	193	116	5	25248b8e65d558b1a96a87c93e3e5b4c0ba168fe
ToppCell	facs-Trachea-18m-Mesenchymal-fibroblast-fibroblast_of_trachea\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	NFIA NFIB NFIX PLAT CHPF	1.50e-04	193	116	5	f1f1097204e07a7bed416425b8256942038a734f
ToppCell	facs-MAT-Fat-24m-Mesenchymal-mesenchymal_progenitor\|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NFIA NFIB NFIC NFIX PLAT	1.50e-04	193	116	5	b45cd02081f97904eaea2d013e1fa980505d060b
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_1\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	ACADL GRPR FREM1 SLC7A2 NFIB	1.54e-04	194	116	5	6ac759828c41ffa974ee82842162caa959351dd1
ToppCell	PND01-03-samps-Mesenchymal\|PND01-03-samps / Age Group, Lineage, Cell class and subclass	FREM1 NFIA NFIB PALLD TNS3	1.54e-04	194	116	5	4f9bd0ded0dde1df885850714f29e73e992539a5
ToppCell	facs-MAT-Fat-18m-Mesenchymal-mesenchymal_stem_cell_of_adipose\|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NFIA NFIB NFIC PLAT TCF7L1	1.54e-04	194	116	5	f906b090f67df4cfe3498cdbb52cc0efa08e06cc
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	KANSL1L MYO9A RNF213 MET GPC4	1.54e-04	194	116	5	e577d9e88390b36b5a09b97fe1026089892275a3
ToppCell	LV-10._Endothelium_II\|LV / Chamber and Cluster_Paper	PKHD1L1 PTGS1 PCDH15 PLAT HS3ST2	1.54e-04	194	116	5	b6cc849fa08599bff9839ef382d190cc964e273e
ToppCell	facs-MAT-Fat-18m-Mesenchymal\|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NFIA NFIB NFIC PLAT TCF7L1	1.54e-04	194	116	5	944cdb0403d80a10a2eea2a3516a9343dbccc32c
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	ACADL GRPR FREM1 SLC7A2 NFIB	1.54e-04	194	116	5	5d0b0d8e96f0e0297a4dba70a05d87081a4eb323
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ACADL PTGS1 FREM1 NFIB TCF7L1	1.54e-04	194	116	5	69bff17df4a760ccf081cf52ff04af02c14f448d
ToppCell	Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	PITPNM2 ACADL MET MAST4 AUTS2	1.54e-04	194	116	5	97534c8bba895a7913665e03ae4e5c4a6ad71daf
ToppCell	facs-Heart-RA-18m-Mesenchymal\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	EPB41L3 NFIA NFIC NFIX TCF7L1	1.54e-04	194	116	5	bc945450b350f597c3ff910d3a14a533d90086a8
Drug	7-biopterin	NFIA NFIB NFIC NFIX	3.97e-07	13	113	4	CID005488923
Drug	A-K-V	NFIA NFIB NFIC NFIX SYMPK	1.06e-06	37	113	5	CID011840919
Drug	pantothenoyl-aminoethenethiol	ASH1L CAPN10 NFIA NFIB NFIC NFIX	1.70e-06	73	113	6	CID000447227
Drug	3-bp	NFIA NFIB NFIC NFIX	2.10e-06	19	113	4	CID005326878
Drug	C8-ceramide	APOB ABCA7 PTGS1 CAPN10 ACSM3 NFIA NFIB NFIC NFIX SCARB1 GAL3ST3 PLAT CHPF	3.95e-06	556	113	13	CID000002508
Drug	NSC325316	NFIA NFIB NFIC NFIX	4.74e-06	23	113	4	CID000331608
Drug	Prilocaine hydrochloride [1786-81-8]; Down 200; 15.6uM; MCF7; HT_HG-U133A	DOK1 KANSL1L IFT140 CAPN10 SLC7A2 NFIB TIMELESS WDFY3	6.18e-06	196	113	8	2314_DN
Drug	Clofazimine [2030-63-9]; Down 200; 8.4uM; MCF7; HT_HG-U133A	KANSL1L IFT140 UTP14A ASH1L PTGS1 CDKAL1 TIMELESS SYMPK	6.42e-06	197	113	8	3239_DN
Drug	Bendroflumethiazide [73-48-3]; Up 200; 9.4uM; MCF7; HT_HG-U133A	DOK1 CCNO SLC7A2 MAST4 NFIB TIMELESS NUP188 RASAL2	6.66e-06	198	113	8	3415_UP
Drug	4alpha-hydroxytetrahydrobiopterin	NFIA NFIB NFIC NFIX	6.71e-06	25	113	4	CID000129803
Drug	Hydroxychloroquine	TLR7 TLR9	2.44e-05	2	113	2	DB01611
Drug	Trimipramine maleate salt [521-78-8]; Down 200; 9.8uM; MCF7; HT_HG-U133A	KANSL1L UTP14A GRPR MET TIMELESS WDFY3 DOCK6	5.28e-05	194	113	7	4163_DN
Drug	Prednisone [53-03-2]; Up 200; 11.2uM; PC3; HT_HG-U133A	IFT140 CDKAL1 KRIT1 ACSM3 NFIB TIMELESS RASAL2	5.45e-05	195	113	7	4577_UP
Drug	Acetopromazine maleate salt [3598-37-6]; Down 200; 9uM; PC3; HT_HG-U133A	CCNO ABCA7 XYLT2 TRIM66 MAST4 NFIB DOCK6	5.63e-05	196	113	7	4494_DN
Drug	Flufenamic acid [530-78-9]; Up 200; 14.2uM; MCF7; HT_HG-U133A	IFT140 PTGS1 CDKAL1 GPC4 WDFY3 FHIP2B SYMPK	5.81e-05	197	113	7	5478_UP
Drug	Rilmenidine hemifumarate [54187-04-1]; Down 200; 8.4uM; HL60; HT_HG-U133A	KANSL1L UTP14A XYLT2 NFIC SCARB1 CHPF FHIP2B	5.81e-05	197	113	7	3133_DN
Drug	Theobromine [83-67-0]; Down 200; 22.2uM; MCF7; HT_HG-U133A	KANSL1L CCNO CDKAL1 CAPN10 EFNA1 SCARB1 DOCK6	5.81e-05	197	113	7	3334_DN
Drug	Megestrol acetate [595-33-5]; Down 200; 10.4uM; MCF7; HT_HG-U133A	CDKAL1 TRIM66 NFIB TIMELESS WDFY3 DOCK6 TNS3	6.00e-05	198	113	7	5013_DN
Drug	Cotinine (-) [486-56-6]; Down 200; 22.6uM; MCF7; HT_HG-U133A	UTP14A CCNO NKRF CDKAL1 XYLT2 MAST4 WDFY3	6.00e-05	198	113	7	5246_DN
Drug	Etidronic acid, disodium salt [7414-83-7]; Up 200; 16uM; MCF7; HT_HG-U133A	ABCA7 GRPR CAPN10 SLC7A2 PLAT LEPROT NUP188	6.00e-05	198	113	7	3325_UP
Drug	Thyroxine (L) [51-48-9]; Up 200; 5.2uM; MCF7; HT_HG-U133A	DOK1 KANSL1L PTGS1 MET SLC7A2 TIMELESS SYMPK	6.20e-05	199	113	7	3249_UP
Drug	Tetrahydrozoline hydrochloride [522-48-5]; Down 200; 16.8uM; MCF7; HT_HG-U133A	MYO9A UTP14A PTGS1 MAST4 NFIB AUTS2 WDFY3	6.20e-05	199	113	7	6069_DN
Disease	myeloid white cell count	RASA2 SLC6A17 HECTD4 NAIP ABCA7 CDKAL1 MET CFAP97D2 NFIA LEPROT RMC1 TCF7L1 RASAL2 TNS3	1.29e-05	937	112	14	EFO_0007988
Disease	lipoprotein measurement	PGS1 APOB SCARB1 LEPROT DOCK6	5.14e-05	105	112	5	EFO_0004732
Disease	Headache	RNF213 NFIB TRPM8 CHSY3	1.05e-04	64	112	4	HP_0002315
Disease	X-13431--nonanoylcarnitine measurement	KANSL1L ACADL	1.42e-04	5	112	2	EFO_0021349
Disease	neutrophil count, eosinophil count	RASA2 HECTD4 ABCA7 CDKAL1 LEPROT TNS3	1.67e-04	213	112	6	EFO_0004833, EFO_0004842
Disease	cholesteryl ester measurement, high density lipoprotein cholesterol measurement	PGS1 RASA2 APOB SCARB1 LEPROT MAPKBP1 DOCK6	1.94e-04	312	112	7	EFO_0004612, EFO_0010351
Disease	total cholesterol measurement, high density lipoprotein cholesterol measurement	PGS1 RASA2 APOB SCARB1 LEPROT MAPKBP1 DOCK6	2.06e-04	315	112	7	EFO_0004574, EFO_0004612
Disease	neutrophil count, basophil count	RASA2 HECTD4 ABCA7 CDKAL1 LEPROT TNS3	2.19e-04	224	112	6	EFO_0004833, EFO_0005090
Disease	neutrophil count	HINT1 RASA2 SLC6A17 ASH1L HECTD4 NAIP ABCA7 CDKAL1 MET SULT6B1 LEPROT RMC1 DOCK6 TCF7L1 TNS3	2.33e-04	1382	112	15	EFO_0004833
Disease	alcohol drinking	HECTD4 NFIB AUTS2 TRPM8	2.61e-04	81	112	4	EFO_0004329
Disease	X-23641 measurement	KANSL1L ACADL	2.96e-04	7	112	2	EFO_0800854
Disease	lipoprotein measurement, phospholipid measurement	APOB SCARB1 LEPROT DOCK6	3.14e-04	85	112	4	EFO_0004639, EFO_0004732
Disease	X-17676 measurement	ACSM3 TAS1R2	3.94e-04	8	112	2	EFO_0800785
Disease	lipoprotein-associated phospholipase A(2) measurement	RNF213 APOB SCARB1	4.75e-04	40	112	3	EFO_0004746
Disease	coronary artery disease	PDS5B IFT140 HINT1 HECTD4 RNF213 APOB MAST4 NFIA NFIB SCARB1 DOCK6 PALLD TNS3	6.07e-04	1194	112	13	EFO_0001645
Disease	fibrinogen measurement, tissue plasminogen activator measurement	HINT1 HECTD4 LEPROT	6.73e-04	45	112	3	EFO_0004623, EFO_0004791
Disease	fibrinogen measurement, plasminogen activator inhibitor 1 measurement	HINT1 HECTD4 LEPROT	6.73e-04	45	112	3	EFO_0004623, EFO_0004792
Disease	cerebral cavernous malformation (implicated_via_orthology)	RNF213 KRIT1	7.68e-04	11	112	2	DOID:0060669 (implicated_via_orthology)
Disease	very low density lipoprotein cholesterol measurement, phospholipids:total lipids ratio	PGS1 DDX56 APOB SCARB1 LEPROT DOCK6	8.72e-04	291	112	6	EFO_0008317, EFO_0020946
Disease	Zellweger Spectrum	PEX6 ABCD3	1.08e-03	13	112	2	C3658299
Disease	Zellweger-Like Syndrome	PEX6 ABCD3	1.08e-03	13	112	2	C0751594
Disease	sleep duration, high density lipoprotein cholesterol measurement	PGS1 APOB SCARB1 DOCK6	1.19e-03	121	112	4	EFO_0004612, EFO_0005271
Disease	Ischemic stroke, fibrinogen measurement	HINT1 HECTD4 LEPROT	1.21e-03	55	112	3	EFO_0004623, HP_0002140
Disease	phospholipids in medium HDL measurement	APOB SCARB1 DOCK6	1.21e-03	55	112	3	EFO_0022295
Disease	factor XI measurement, fibrinogen measurement, tissue plasminogen activator measurement, factor VII measurement	HINT1 HECTD4 LEPROT	1.27e-03	56	112	3	EFO_0004619, EFO_0004623, EFO_0004694, EFO_0004791
Disease	free cholesterol measurement, high density lipoprotein cholesterol measurement	PGS1 APOB SCARB1 LEPROT MAPKBP1 DOCK6	1.31e-03	315	112	6	EFO_0004612, EFO_0008591
Disease	Disorder of eye	FREM1 GPR179 FAM161A PCDH15 PITPNM3	1.31e-03	212	112	5	C0015397
Disease	total lipids in medium HDL measurement	APOB SCARB1 DOCK6	1.41e-03	58	112	3	EFO_0022310
Disease	free cholesterol in medium HDL measurement	APOB SCARB1 DOCK6	1.41e-03	58	112	3	EFO_0022267
Disease	fibrinogen measurement, factor VII measurement	HINT1 HECTD4 LEPROT	1.41e-03	58	112	3	EFO_0004619, EFO_0004623
Disease	phospholipid measurement, high density lipoprotein cholesterol measurement	PEX6 APOB SCARB1 LEPROT DOCK6 RASAL2	1.44e-03	321	112	6	EFO_0004612, EFO_0004639
Disease	Sarcomatoid Renal Cell Carcinoma	DNHD1 MET SCARB1 RNF139	1.46e-03	128	112	4	C1266043
Disease	Chromophobe Renal Cell Carcinoma	DNHD1 MET SCARB1 RNF139	1.46e-03	128	112	4	C1266042
Disease	Collecting Duct Carcinoma of the Kidney	DNHD1 MET SCARB1 RNF139	1.46e-03	128	112	4	C1266044
Disease	esterified cholesterol measurement	APOB SSH1 LEPROT DOCK6	1.46e-03	128	112	4	EFO_0008589
Disease	Papillary Renal Cell Carcinoma	DNHD1 MET SCARB1 RNF139	1.46e-03	128	112	4	C1306837
Disease	Renal Cell Carcinoma	DNHD1 MET SCARB1 RNF139	1.46e-03	128	112	4	C0007134
Disease	cholesterol in medium HDL measurement	APOB SCARB1 DOCK6	1.48e-03	59	112	3	EFO_0021903
Disease	choline measurement	APOB SCARB1 LEPROT DOCK6	1.55e-03	130	112	4	EFO_0010116
Disease	polyunsaturated fatty acid measurement	APOB NFIB SCARB1 DOCK6	1.59e-03	131	112	4	EFO_0010733
Disease	free cholesterol in HDL measurement	APOB SCARB1 DOCK6	1.63e-03	61	112	3	EFO_0022264
Disease	phospholipids in HDL measurement	APOB SCARB1 DOCK6	1.63e-03	61	112	3	EFO_0022293
Disease	Zellweger Syndrome	PEX6 ABCD3	1.65e-03	16	112	2	C0043459
Disease	Synostotic Posterior Plagiocephaly	FREM1 IFT122	1.65e-03	16	112	2	C1833340
Disease	Craniosynostosis, Type 1	FREM1 IFT122	1.65e-03	16	112	2	C4551902
Disease	Acrocephaly	FREM1 IFT122	1.65e-03	16	112	2	C0030044
Disease	Trigonocephaly	FREM1 IFT122	1.65e-03	16	112	2	C0265535
Disease	Scaphycephaly	FREM1 IFT122	1.65e-03	16	112	2	C0265534
Disease	Synostotic Anterior Plagiocephaly	FREM1 IFT122	1.65e-03	16	112	2	C2931150
Disease	Metopic synostosis	FREM1 IFT122	1.65e-03	16	112	2	C1860819
Disease	lipid measurement, high density lipoprotein cholesterol measurement	PGS1 APOB SCARB1 LEPROT MAPKBP1 DOCK6	1.66e-03	330	112	6	EFO_0004529, EFO_0004612
Disease	oral squamous cell carcinoma (is_marker_for)	NAIP MET DOCK6	1.79e-03	63	112	3	DOID:0050866 (is_marker_for)
Disease	total lipids in HDL measurement	APOB SCARB1 DOCK6	1.79e-03	63	112	3	EFO_0022307
Disease	Eye Abnormalities	FREM1 IFT122	1.87e-03	17	112	2	C0015393
Disease	Brachycephaly	FREM1 IFT122	1.87e-03	17	112	2	C0221356
Disease	perinatal necrotizing enterocolitis (biomarker_via_orthology)	TLR7 TLR9	1.87e-03	17	112	2	DOID:8677 (biomarker_via_orthology)
Disease	venous thromboembolism, fibrinogen measurement	HINT1 HECTD4 LEPROT	2.14e-03	67	112	3	EFO_0004286, EFO_0004623
Disease	waist-hip ratio	HECTD4 CDKAL1 TRIM66 SLC7A2 EFNA1 MAST4 NFIX IFT122 MAPKBP1 RMC1 DOCK6 SYMPK	2.42e-03	1226	112	12	EFO_0004343
Disease	Conventional (Clear Cell) Renal Cell Carcinoma	DNHD1 MET SCARB1 RNF139	2.48e-03	148	112	4	C0279702
Disease	Alzheimer disease, educational attainment	PITPNM2 ABCA7 EFNA1 NFIB NFIX	2.56e-03	247	112	5	EFO_0011015, MONDO_0004975
Disease	Craniosynostosis	FREM1 IFT122	2.59e-03	20	112	2	C0010278
Disease	phospholipids in large HDL measurement	APOB SCARB1 DOCK6	2.73e-03	73	112	3	EFO_0022190
Disease	total lipids in large HDL	APOB SCARB1 DOCK6	2.84e-03	74	112	3	EFO_0022189
Disease	level of Phosphatidylinositol (18:0_18:2) in blood serum	FAM161A DOCK6	2.86e-03	21	112	2	OBA_2045156
Disease	fibrinogen measurement, coronary artery disease	HINT1 HECTD4 SCARB1 LEPROT	2.86e-03	154	112	4	EFO_0001645, EFO_0004623
Disease	granulocyte count	RASA2 HECTD4 CDKAL1 LEPROT TNS3	2.89e-03	254	112	5	EFO_0007987
Disease	mean corpuscular hemoglobin concentration	PDS5B IFT140 PGS1 HECTD4 ABCA7 CDKAL1 CHTF18 SCARB1 LEPROT CCNI TNS3	3.23e-03	1105	112	11	EFO_0004528
Disease	very low density lipoprotein cholesterol measurement, cholesteryl esters:total lipids ratio	PITPNM2 PGS1 HECTD4 DDX56 APOB	3.40e-03	264	112	5	EFO_0008317, EFO_0020944
Disease	platelet crit	PGS1 APOB GPATCH8 MAST4 USP38 NFIA NFIC NFIX LEPROT RASAL2	3.41e-03	952	112	10	EFO_0007985
Disease	free cholesterol in large HDL measurement	APOB SCARB1 DOCK6	3.41e-03	79	112	3	EFO_0022157
Disease	prostate carcinoma (is_marker_for)	BCL2L14 MET	3.43e-03	23	112	2	DOID:10286 (is_marker_for)
Disease	cholesterol in large HDL measurement	APOB SCARB1 DOCK6	3.54e-03	80	112	3	EFO_0021900

Protein segments in the cluster

Peptide	Gene	Start	Entry
HPESLSLLRSIHFPI	NAIP	906	Q13075
FFSFLHVHTPLPTTD	ARSF	286	P54793
LPVAFHVLFASSHTP	CHTF18	701	Q8WVB6
HVLFASSHTPRITFP	CHTF18	706	Q8WVB6
LMHFPPTSFDSALRH	ARID5A	551	Q03989
RSHHFIPRDLLPTIF	ASH1L	1306	Q9NR48
PHARSEDVPDHLFFV	C1orf140	81	Q5VVS0
PTISFFLEHFTHARV	CCNO	231	P22674
HEAPSPAHGISLFLV	ACADL	221	P28330
PVPFHDKELTAQHFR	ADGB	826	Q8N7X0
TPLDFLHIFHAIAVS	CCNI	146	Q14094
TRHHVFKSTPALFSP	BCL2L14	31	Q9BZR8
RPSDTEFHPIGFHIF	CAPN10	566	Q9HC96
SPIHPAFSSSHLRLL	DNHD1	2411	Q96M86
HPRNLSSPFIFHEKT	SLC7A2	641	P52569
FFILVAVRHSHPPLE	ABCA7	36	Q8IZY2
EFHPFIEALLPHVRA	NFIA	11	Q12857
EDFPHIRSALLPVLH	PDS5B	701	Q9NTI5
DEFHPFIEALLPHVR	NFIB	11	O00712
RFFAVAVVSPHTFHL	RASA2	511	Q15283
FTIHLPHAPSLDISR	LARGE2	661	Q8N3Y3
GHRSPVTRVIFHPVF	PAFAH1B1	106	P43034
ISIFVNPAGIPHFVH	NXF3	181	Q9H4D5
SPLHLAARFGHPVLV	ESPNL	106	Q6ZVH7
VHPDVRALGTEPHFF	HS3ST2	136	Q9Y278
LFVLIFHAISPIPHF	LEPROT	36	O15243
FHAISPIPHFIAKRV	LEPROT	41	O15243
LSLPSDVPLHFHFET	KANSL1L	636	A0AUZ9
PHDHHSVTLRAPEFL	KIAA0100	1221	Q14667
AIARTRFPSHFVHPT	LETM2	11	Q2VYF4
EFHPFIEALLPHVRA	NFIX	11	Q14938
HTEDPFSVHRPETLF	IFT122	961	Q9HBG6
FHTARFVLVPSLHPD	GPR179	591	Q6PRD1
ISESAFSARFRPHHP	GPC4	356	O75487
SHTFDFHFNLPPRLP	ARRDC5	106	A6NEK1
IHFHVHRYPIDTLPT	LCLAT1	281	Q6UWP7
FHHVSAVLNFDLPPT	DDX56	351	Q9NY93
VSSLLLHLRPFPVDH	C9orf131	281	Q5VYM1
RFSPPHSSLNHEFFR	MGAT5B	556	Q3V5L5
ATFLASHPIHIIPAS	GPATCH8	1431	Q9UKJ3
TSVLSRLALFPHPHI	FHIP2B	626	Q86V87
DFILLGIFNHSPPHT	OR2M2	11	Q96R28
FPEQVRVSLFHTPHL	PGS1	186	Q32NB8
PFARELHIEIVSSPH	PEX6	316	Q13608
TITTPPFFSFSHRHL	FREM1	681	Q5H8C1
HPHDLARPSTLFSAA	AUTS2	701	Q8WXX7
KAFIRPFREHHIDPT	PEDS1	111	A5PLL7
FEFFSLPPLHSITVH	RASAL2	216	Q9UJF2
ERHAQSHFIPALFRP	KRIT1	166	O00522
FHDISPQAPTHFLVI	HINT1	41	P49773
PLSETRFHHVAQAFL	LINC00336	111	Q6ZUF6
LRPSPSFTHFLLTHG	PTGS1	81	P23219
LTAFPTVALPHLFHA	PITPNM2	931	Q9BZ72
FAPKLPHLFTRLFHI	HECTD4	2456	Q9Y4D8
PHLFTRLFHIPAIRD	HECTD4	2461	Q9Y4D8
EHLSPPFREALHELA	ECEL1	411	O95672
PHSALHFPAAPRFIQ	PALLD	261	Q8WX93
FLFSLHEPFQTHLPT	NPAS4	436	Q8IUM7
IRSPEVKHFFALHPF	PCDH15	856	Q96QU1
FAERHNLTVALPHPS	GAL3ST3	86	Q96A11
FSAHFVHPATRPPHV	GAL3ST3	111	Q96A11
FQLPHISHTIEVPTF	APOB	2741	P04114
HFIPFHPVTAENDFL	DOCK2	346	Q92608
LASPEPLVAFSHHVL	DOCK6	766	Q96HP0
PASPHGVARLEFFDH	DOK1	31	Q99704
LHSIGHSAAPRLFPL	EFNA1	176	P20827
QPETEFVFPLSHLHL	DBNDD2	126	Q9BQY9
FVFPLSHLHLESQRP	DBNDD2	131	Q9BQY9
HPRVYAFLHIPVQSA	CDKAL1	311	Q5VV42
LAIPEAVFSDLHPFH	GRPR	171	P30550
VSFLHFDSHPDLLIP	C5orf22	46	Q49AR2
PLVDTRAPLTFRHLH	CFAP97D2	36	A0A1B0GU71
LPSFRVSTLPLESHH	MAST4	2521	O15021
HFLSTLPRPHALGTD	MAPKBP1	311	O60336
PFDLHASPHASIKRE	FAM161A	456	Q3B820
EEHGFLLHESFPRPA	IFT140	701	Q96RY7
SELPFDAHAHILPRA	CREB3L4	156	Q8TEY5
VEHHTFFRLLLPEAP	EPB41L3	381	Q9Y2J2
SHVSSFRRHFPVLFV	RNF139	381	Q8WU17
HVNFLLDSHPVSPEV	MET	476	P08581
AVSFLHFHNDVPDIP	SULT6B1	146	Q6IMI4
RSPRVHHFSPVLHFP	TOR2A	116	Q8N2E6
FHARPRFEPVHFVAS	NKRF	51	O15226
RVSVHPHRLHPSFDF	RNF165	131	Q6ZSG1
ALPFTPKSIRSHFQH	SIPA1L2	716	Q9P2F8
LLESRPFPAAHHAFL	SIX5	146	Q8N196
FLSHPHFLNADPVLA	SCARB1	341	Q8WTV0
CHPLRYPSIITDHFV	OR56A3	131	Q8NH54
RDFPPSLLHLHPQFA	RNF220	86	Q5VTB9
FAAQASHHLVPPEII	SDAD1	356	Q9NVU7
SPLFLHFVILHGTPN	TNS3	176	Q68CZ2
DEFHPFIEALLPHVR	NFIC	11	P08651
AFLPHITSSPVAHLA	SSH1	681	Q8WYL5
LVVSRPFLDLSHPRH	ABCD3	331	P28288
ACVFTHHLPRFEPTS	ACSM3	296	Q53FZ2
FLHFSSLHVLRAVEP	CHPF	711	Q8IZ52
PFRSQEVGVVHIFHP	CHSY3	821	Q70JA7
RSPRVHHFSPVLHFP	TOR2A	116	Q5JU69
VFFHAIISLHFPFNP	RNF213	381	Q63HN8
PKEPSFRHHFLQVLT	TIMELESS	101	Q9UNS1
AHCFQERFPPHHLTV	PLAT	356	P00750
PLEVTFHVRATLPHF	nan	81	Q6ZSR3
FIFPSFLRVHERIHT	ZNF791	281	Q3KP31
AFHFPHLLSPQIQRS	TMEM175	161	Q9BSA9
FFHHLDNLRPSLTPV	WDFY3	3001	Q8IZQ1
LFHGATFVPRVPLHV	MRPL38	161	Q96DV4
SFPATLHAHQALPVL	TCF7L1	561	Q9HCS4
FDGSVTFHHPVLPAR	RMC1	296	Q96DM3
HFPQLHPDTFSHLSR	TLR9	271	Q9NR96
TDLRHTGFLPFVAHP	NUP188	631	Q5SRE5
HAAAHQVRVLPYPFT	UTP14A	676	Q9BVJ6
PVERSAFPVHHVAFV	PKHD1L1	4066	Q86WI1
HIPDISPASFHRLDH	TLR7	76	Q9NYK1
FQHSPEAFHLIVPHV	USP38	341	Q8NB14
RFPALLRTTPSADHH	TAS1R2	176	Q8TE23
VLTAFPTVALPHLFH	PITPNM3	561	Q9BZ71
LSTFRSHYVPHELIP	SAXO2	316	Q658L1
LREPLLAHVRSFTPH	SYMPK	1071	Q92797
SSFHSHLPELHIFQP	ZNF888	141	P0CJ79
PIPVVFVLRHFHLLS	SLC6A17	631	Q9H1V8
IRQLSFHFPPRVTGH	TLDC2	61	A0PJX2
HDVSPITRHPLQALF	TRPM8	551	Q7Z2W7
FTSHRLVEPVPDTHL	MID2	176	Q9UJV3
VFHLSCHVPALLSFP	TRIM66	991	O15016
FARLSLHHAATAAPP	XYLT2	561	Q9H1B5
LDLPFPSHHQRFSIF	ZP4	406	Q12836
FVSHFHVLLPRNIIP	MYO9A	961	B2RTY4